John M. Murabito Sells 28,037 Shares of CIGNA Co. (CI) Stock

CIGNA Co. (NYSE:CI) EVP John M. Murabito sold 28,037 shares of the business’s stock in a transaction that occurred on Wednesday, January 10th. The stock was sold at an average price of $205.68, for a total transaction of $5,766,650.16. Following the completion of the sale, the executive vice president now directly owns 60,290 shares of the company’s stock, valued at $12,400,447.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of CIGNA Co. (NYSE:CI) opened at $213.39 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. The stock has a market cap of $52,610.00, a price-to-earnings ratio of 23.37, a P/E/G ratio of 1.43 and a beta of 0.51. CIGNA Co. has a 1-year low of $133.52 and a 1-year high of $213.73.

CIGNA (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.36 by $0.47. The business had revenue of $10.38 billion during the quarter, compared to the consensus estimate of $10.17 billion. CIGNA had a net margin of 5.74% and a return on equity of 18.85%. CIGNA’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.94 EPS. analysts anticipate that CIGNA Co. will post 10.34 earnings per share for the current year.

CI has been the subject of several recent research reports. Piper Jaffray Companies reissued a “buy” rating and issued a $191.00 target price on shares of CIGNA in a research report on Sunday, September 17th. Zacks Investment Research raised shares of CIGNA from a “hold” rating to a “buy” rating and set a $214.00 target price for the company in a research report on Monday, October 9th. Jefferies Group boosted their target price on shares of CIGNA from $201.00 to $221.00 and gave the stock a “buy” rating in a research report on Friday, October 13th. BMO Capital Markets assumed coverage on shares of CIGNA in a report on Monday, October 16th. They set a “market perform” rating and a $210.00 price objective for the company. Finally, Credit Suisse Group assumed coverage on shares of CIGNA in a report on Thursday, November 2nd. They set an “outperform” rating and a $219.00 price objective for the company. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $205.18.

A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in CIGNA by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after purchasing an additional 424,469 shares during the last quarter. FMR LLC raised its stake in CIGNA by 6.7% during the 2nd quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after purchasing an additional 432,978 shares during the last quarter. Ameriprise Financial Inc. raised its stake in CIGNA by 4.8% during the 3rd quarter. Ameriprise Financial Inc. now owns 3,776,414 shares of the health services provider’s stock valued at $705,889,000 after purchasing an additional 171,712 shares during the last quarter. FIL Ltd raised its stake in CIGNA by 5.2% during the 2nd quarter. FIL Ltd now owns 2,311,938 shares of the health services provider’s stock valued at $386,996,000 after purchasing an additional 113,531 shares during the last quarter. Finally, Investec Asset Management LTD raised its stake in CIGNA by 35.4% during the 3rd quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock valued at $345,764,000 after purchasing an additional 483,904 shares during the last quarter. Hedge funds and other institutional investors own 87.74% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/14/john-m-murabito-sells-28037-shares-of-cigna-co-ci-stock.html.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply